VERV logo

Verve Therapeutics (VERV) Cash From Operations

Annual CFO

-$157.69 M
-$8.14 M-5.45%

December 31, 2024


Summary


Performance

VERV Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherVERVcash flowmetrics:

Quarterly CFO

-$40.84 M
-$1.24 M-3.13%

December 1, 2024


Summary


Performance

VERV Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherVERVcash flowmetrics:

TTM CFO

-$157.69 M
-$165.00 K-0.10%

December 1, 2024


Summary


Performance

VERV TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherVERVcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

VERV Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-5.5%0.0%0.0%
3 y3 years-102.5%-245.8%-11.2%
5 y5 years-2019.0%-245.8%-11.2%

VERV Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-102.5%at low-245.8%+16.8%-102.5%+0.9%
5 y5-year-2019.0%at low-545.9%+16.8%-2211.5%+0.9%
alltimeall time-2019.0%at low-545.9%+16.8%-2211.5%+0.9%

Verve Therapeutics Cash From Operations History

DateAnnualQuarterlyTTM
Dec 2024
-$157.69 M(+5.4%)
-
-
Dec 2024
-
-$40.84 M(+3.1%)
-$157.69 M(+0.1%)
Sep 2024
-
-$39.61 M(+16.0%)
-$157.53 M(+21.4%)
Jun 2024
-
-$34.16 M(-20.7%)
-$129.73 M(-9.6%)
Mar 2024
-
-$43.08 M(+5.9%)
-$143.53 M(-4.0%)
Dec 2023
-$149.55 M(+22.2%)
-$40.68 M(+244.4%)
-$149.55 M(+5.5%)
Sep 2023
-
-$11.81 M(-75.4%)
-$141.76 M(-10.9%)
Jun 2023
-
-$47.96 M(-2.3%)
-$159.13 M(+15.4%)
Mar 2023
-
-$49.10 M(+49.3%)
-$137.92 M(+12.7%)
Dec 2022
-$122.33 M
-$32.89 M(+12.7%)
-$122.33 M(+4.1%)
Sep 2022
-
-$29.18 M(+9.0%)
-$117.48 M(+7.1%)
DateAnnualQuarterlyTTM
Jun 2022
-
-$26.76 M(-20.1%)
-$109.66 M(+13.9%)
Mar 2022
-
-$33.51 M(+19.5%)
-$96.25 M(+23.6%)
Dec 2021
-$77.88 M(+120.8%)
-$28.04 M(+31.3%)
-$77.88 M(+20.2%)
Sep 2021
-
-$21.36 M(+60.1%)
-$64.81 M(+30.2%)
Jun 2021
-
-$13.34 M(-11.9%)
-$49.78 M(+14.2%)
Mar 2021
-
-$15.14 M(+1.1%)
-$43.58 M(+23.6%)
Dec 2020
-$35.27 M(+373.9%)
-
-
Dec 2020
-
-$14.97 M(+136.8%)
-$35.27 M(+73.8%)
Sep 2020
-
-$6.32 M(-11.5%)
-$20.29 M(+45.3%)
Jun 2020
-
-$7.14 M(+4.7%)
-$13.97 M(+104.7%)
Mar 2020
-
-$6.82 M
-$6.82 M
Dec 2019
-$7.44 M
-
-

FAQ

  • What is Verve Therapeutics annual cash flow from operations?
  • What is the all time high annual CFO for Verve Therapeutics?
  • What is Verve Therapeutics annual CFO year-on-year change?
  • What is Verve Therapeutics quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Verve Therapeutics?
  • What is Verve Therapeutics quarterly CFO year-on-year change?
  • What is Verve Therapeutics TTM cash flow from operations?
  • What is the all time high TTM CFO for Verve Therapeutics?
  • What is Verve Therapeutics TTM CFO year-on-year change?

What is Verve Therapeutics annual cash flow from operations?

The current annual CFO of VERV is -$157.69 M

What is the all time high annual CFO for Verve Therapeutics?

Verve Therapeutics all-time high annual cash flow from operations is -$7.44 M

What is Verve Therapeutics annual CFO year-on-year change?

Over the past year, VERV annual cash flow from operations has changed by -$8.14 M (-5.45%)

What is Verve Therapeutics quarterly cash flow from operations?

The current quarterly CFO of VERV is -$40.84 M

What is the all time high quarterly CFO for Verve Therapeutics?

Verve Therapeutics all-time high quarterly cash flow from operations is -$6.32 M

What is Verve Therapeutics quarterly CFO year-on-year change?

Over the past year, VERV quarterly cash flow from operations has changed by $0.00 (0.00%)

What is Verve Therapeutics TTM cash flow from operations?

The current TTM CFO of VERV is -$157.69 M

What is the all time high TTM CFO for Verve Therapeutics?

Verve Therapeutics all-time high TTM cash flow from operations is -$6.82 M

What is Verve Therapeutics TTM CFO year-on-year change?

Over the past year, VERV TTM cash flow from operations has changed by $0.00 (0.00%)